Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Operating Leases: 2022-2024

Historic Operating Leases for Biofrontera (BFRI) over the last 3 years, with Dec 2024 value amounting to $276,000.

  • Biofrontera's Operating Leases fell 58.02% to $136,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $136,000, marking a year-over-year decrease of 58.02%. This contributed to the annual value of $276,000 for FY2024, which is 65.67% down from last year.
  • As of FY2024, Biofrontera's Operating Leases stood at $276,000, which was down 65.67% from $804,000 recorded in FY2023.
  • In the past 5 years, Biofrontera's Operating Leases ranged from a high of $848,000 in FY2022 and a low of $276,000 during FY2024.
  • Over the past 3 years, Biofrontera's median Operating Leases value was $804,000 (recorded in 2023), while the average stood at $642,667.
  • Data for Biofrontera's Operating Leases shows a maximum YoY tumbled of 65.67% (in 2024) over the last 5 years.
  • Biofrontera's Operating Leases (Yearly) stood at $848,000 in 2022, then fell by 5.19% to $804,000 in 2023, then crashed by 65.67% to $276,000 in 2024.